Mobile Acceptance and Commitment Therapy in Bipolar Disorder: Microrandomized Trial

Mobile interventions promise to fill in gaps in care with their broad reach and flexible delivery. Our goal was to investigate delivery of a mobile version of acceptance and commitment therapy (ACT) for individuals with bipolar disorder (BP). Individuals with BP (n=30) participated in a 6-week micro...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:JMIR mental health 2023-04, Vol.10, p.e43164-e43164
Hauptverfasser: Cochran, Amy, Maronge, Jacob M, Victory, Amanda, Hoel, Sydney, McInnis, Melvin G, Thomas, Emily Bk
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Mobile interventions promise to fill in gaps in care with their broad reach and flexible delivery. Our goal was to investigate delivery of a mobile version of acceptance and commitment therapy (ACT) for individuals with bipolar disorder (BP). Individuals with BP (n=30) participated in a 6-week microrandomized trial. Twice daily, participants logged symptoms in the app and were repeatedly randomized (or not) to receive an ACT intervention. Self-reported behavior and mood were measured as the energy devoted to moving toward valued domains or away from difficult emotions and with depressive d and manic m scores from the digital survey of mood in BP survey (digiBP). Participants completed an average of 66% of in-app assessments. Interventions did not significantly impact the average toward energy or away energy but did significantly increase the average manic score m (P=.008) and depressive score d (P=.02). This was driven by increased fidgeting and irritability and interventions focused on increasing awareness of internal experiences. The findings of the study do not support a larger study on the mobile ACT in BP but have significant implications for future studies seeking mobile therapy for individuals with BP. ClinicalTrials.gov NCT04098497; https://clinicaltrials.gov/ct2/show/NCT04098497.
ISSN:2368-7959
2368-7959
DOI:10.2196/43164